International Flavors & Fragrances Inc. Shs Unsponsored Brazilian Depositary Receipt Repr 1/2 ShInternational Flavors & Fragrances Inc. Shs Unsponsored Brazilian Depositary Receipt Repr 1/2 ShInternational Flavors & Fragrances Inc. Shs Unsponsored Brazilian Depositary Receipt Repr 1/2 Sh

International Flavors & Fragrances Inc. Shs Unsponsored Brazilian Depositary Receipt Repr 1/2 Sh

No trades

Key facts today


Citigroup has raised the price target for International Flavors & Fragrances (IFF) shares to $83.00 from a previous target of $77.00, while maintaining its 'Buy' rating.
International Flavors & Fragrances (IFF) will announce its Q4 and full year 2025 earnings on February 11, 2026, after market close, with a webcast on February 12 at 9:00 a.m. ET.
Analyze the impactAnalyze the impact
Market capitalization
‪97.77 B‬BRL
−0.00BRL
‪1.31 B‬BRL
‪61.91 B‬BRL
Beta (1Y)
−0.06

About International Flavors & Fragrances, Inc.


CEO
Jon Erik Fyrwald
Website
Headquarters
New York
Founded
1833
Identifiers
2
ISIN BRI1FFBDR003
International Flavors & Fragrances, Inc. engages in the manufacture and supply of flavors and fragrances used in the food, beverage, personal care, and household products industries. It operates through the following segments: Nourish, Health & Biosciences, Scent and Pharma Solutions. The Nourish segment consists of legacy Taste segment combined with N&B's Food & Beverage division and the food protection business of N&B's Health & Biosciences division. The Health & Biosciences business consists of a biotechnology-driven portfolio of enzymes, food cultures, probiotics and specialty ingredients for food, home and personal care, and health and wellness applications. The Scent business creates fragrance compounds, fragrance ingredients and cosmetic ingredients that are integral elements in the world’s finest perfumes and best-known household and personal care products. The Pharma Solutions business produces a vast portfolio including cellulosics and seaweed-based pharma excipients, used to improve the functionality and delivery of active pharmaceutical ingredients, including controlled or modified drug release formulations, and enabling. The company was founded in 1833 and is headquartered in New York, NY.

Check out other big names from the same industry as I1FF34.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:

See all ideas 

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.